Close Menu

NEW YORK (360Dx) – The chief executive and a marketing executive of a New Jersey medical testing laboratory were sentenced to federal prison this week for their roles in a scheme in which Maryland pain management clinics referred urine specimens to the lab in return for $1.37 million in kickbacks, the US Attorney's Office District of Maryland announced on Friday.

Konstantin Bas, CEO of Accu Reference, was sentenced to a year and a day in prison, followed by three years of supervised release for his role in the scheme. He was ordered to forfeit $241,600 and pay a fine of $5,000.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug
19
Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.